サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1597098

欧州の色素沈着症治療の将来予測 (2030年まで) - 地域別分析：治療の種類別、症状別、エンドユーザー別

Europe Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type, Condition, and End User

出版日
ページ情報
英文 90 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
欧州の色素沈着症治療の将来予測 (2030年まで) - 地域別分析：治療の種類別、症状別、エンドユーザー別
出版日: 2024年10月03日
発行: The Insight Partners
ページ情報: 英文 90 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の色素沈着症治療市場は、2022年に11億99万米ドルと評価され、2030年には19億1,195万米ドルに達すると予測され、2022年から2030年までのCAGRは7.1%と推定されます。

色素沈着症啓発プログラムの増加が欧州の色素沈着症治療市場を牽引

紫外線によって誘発される皮膚の色素沈着についての認識を高めるキャンペーンは、これらの疾患の予防、スクリーニング、診断、治療について一般市民を教育するために不可欠であり、これらの疾患を管理するために良質の日焼け止め製品を使用することの重要性についても議論されます。

2022年5月25日、Bella Auroraは国際色素沈着の日を祝いました。皮膚色素沈着の調査において130年以上の経験を持つBella Auroraは、スペインとイタリア全土の著名な皮膚科医、薬剤師、オピニオンリーダーの支援を得て、この日を祝う国際的な啓発キャンペーンを開始しました。2021年6月、Dermalogica Clearは、肌の受容を促し、炎症後色素沈着、にきび、吹き出物などについて聴衆を教育するキャンペーンを開始しました。

肝斑やその他の色素沈着疾患に対する認識の高まりは、革新的で効果的な治療製品や処置に対する需要の急増につながっています。さらに、社会が色素沈着をどのように理解し、どのように対処するかという点においても、重要かつ前向きな変化がもたらされています。したがって、啓発プログラムの増加が色素沈着症治療市場の成長を後押ししています。

欧州の色素沈着症治療市場概要

欧州の色素沈着症治療市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。2023年の欧州の色素沈着症治療市場シェアはドイツが最大。国民の間でスキンケアや皮膚科的健康に対する意識が高まり、重視されるようになったことなどが市場成長を牽引しています。ドイツ人は、肝斑、老人斑、炎症後色素沈着などの色素沈着障害に対処するための先進的なスキンケアソリューションを求めることにますます積極的になっており、市場における革新的な治療に対する需要を牽引しています。さらに、ドイツでは高齢化人口が増加しているため、色素沈着をはじめとする加齢に関連した肌の悩みが数多く生じており、輝きのある肌を維持するために専門的な治療を求める人が増えています。ドイツ連邦統計局 (Statistisches Bundesamt) によると、67歳以上の人口は2030年代半ばまでに400万人から少なくとも2,000万人に増加するといいます。スキンケアとアンチエイジングの解決策を重視する文化は、人口の高齢化と高い皮膚病有病率と相まって、ドイツにおける色素沈着症治療の需要に寄与しています。さらに、外見に対する関心と懸念の高まりは、さまざまな美容施術の需要を増大させる重要な要因であり続け、市場の力強い成長に寄与しています。さらに、ドイツには高度な医療インフラ、熟練した皮膚科医、評判の高い美容クリニックが存在するため、幅広い色素沈着治療や施術を受けやすく、質の高いスキンケアサービスを求める国内外の患者を惹きつけています。

欧州の色素沈着症治療市場の収益と2030年までの予測 (単位：100万米ドル)

欧州の色素沈着症治療市場のセグメンテーション

欧州の色素沈着症治療市場は、治療の種類別、症状別、エンドユーザー別、国別に分類されます。

治療の種類別に見ると、欧州の色素沈着症治療市場は、コスメシューティカル、光線・レーザー治療、マイクロダーマブレーション、ケミカルピーリング、凍結療法、その他に区分されます。2022年には、コスメシューティカル部門が最大の市場シェアを占めました。

症状別に見ると、欧州の色素沈着症治療市場は、肝斑、日光黒子、炎症後色素沈着、その他に区分されます。肝斑セグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別に見ると、欧州の色素沈着症治療市場は病院、皮膚科センター、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、欧州の色素沈着症治療市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。ドイツは、2022年の欧州の色素沈着症治療市場シェアを独占しました。

AbbVie Inc、Bayer AG、EpiPharm AG、Galderma SA、L'OREAL S.A.、Lutronic Co Ltd、Obagi Cosmeceuticals LLC、Pierre Fabre SAなどが、欧州の色素沈着症治療市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 欧州の色素沈着症治療市場：主な市場力学

  • 欧州の色素沈着症治療市場：主な市場力学
  • 市場促進要因
    • 肝斑の有病率の上昇
    • 色素沈着症啓発プログラムの増加
  • 市場抑制要因
    • 治療費の高騰
  • 市場機会
    • 市場参入企業の戦略的取り組み
  • 今後の動向
    • 切除レーザーの使用
    • PATH-3技術に基づく新製品
  • 促進要因と抑制要因の影響

第5章 欧州の色素沈着症治療市場の分析

  • 欧州の色素沈着症治療市場の収益 (2020～2030年)

第6章 欧州の色素沈着症治療市場分析：治療の種類別

  • コスメシューティカル
  • 光線療法/レーザー療法
  • マイクロダーマブレーション
  • ケミカルピーリング
  • 凍結療法
  • その他

第7章 欧州の色素沈着症治療市場分析：症状別

  • 肝斑
  • 日光黒子
  • 炎症後色素沈着
  • その他

第8章 欧州の色素沈着症治療市場分析：エンドユーザー別

  • 病院
  • 皮膚科センター
  • その他

第9章 欧州の色素沈着症治療市場：国別分析

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第10章 色素沈着症治療市場：業界情勢

  • 色素沈着症治療市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第11章 企業プロファイル

  • AbbVie Inc
  • EpiPharm AG
  • Galderma SA
  • Obagi Cosmeceuticals LLC
  • Bayer AG
  • Lutronic Co Ltd
  • L'OREAL S.A.
  • Pierre Fabre SA

第12章 付録

図表

List Of Tables

  • Table 1. Europe Hyperpigmentation Disorder Treatment Market Segmentation
  • Table 2. Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
  • Table 3. Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
  • Table 4. Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 5. Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 6. Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
  • Table 7. Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
  • Table 8. Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 9. UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
  • Table 10. UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
  • Table 11. UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 12. France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
  • Table 13. France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
  • Table 14. France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 15. Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
  • Table 16. Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
  • Table 17. Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 18. Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
  • Table 19. Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
  • Table 20. Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 21. Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
  • Table 22. Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
  • Table 23. Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 24. Recent Organic Growth Strategies in Hyperpigmentation Disorder Treatment Market
  • Table 25. Recent Inorganic Growth Strategies in the Hyperpigmentation Disorder Treatment Market
  • Table 26. Glossary of Terms, Hyperpigmentation Disorder Treatment Market

List Of Figures

  • Figure 1. Europe Hyperpigmentation Disorder Treatment Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030
  • Figure 4. Europe Hyperpigmentation Disorder Treatment Market Share (%) - by Treatment Type (2022 and 2030)
  • Figure 5. Cosmeceutical: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Light or Laser Therapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Microdermabrasion: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Chemical Peels: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Cryotherapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Europe Hyperpigmentation Disorder Treatment Market Share (%) - by Condition (2022 and 2030)
  • Figure 12. Melasma: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Solar Lentigines: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Post-inflammatory Hyperpigmentation: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Hyperpigmentation Disorder Treatment Market Share (%) - by End User (2022 and 2030)
  • Figure 17. Hospitals: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Dermatology Centers: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Hyperpigmentation Disorder Treatment Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 21. Europe Hyperpigmentation Disorder Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 22. Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Growth Strategies in Hyperpigmentation Disorder Treatment Market
目次
Product Code: BMIRE00030847

The Europe hyperpigmentation disorder treatment market was valued at US$ 1,100.99 million in 2022 and is expected to reach US$ 1,911.95 million by 2030; it is estimated to register a CAGR of 7.1% from 2022 to 2030.

Increasing Number of Hyperpigmentation Disorder Awareness Programs Drives Europe Hyperpigmentation Disorder Treatment Market

Campaigns to raise awareness about UV-induced skin hyperpigmentation are essential to educate the general populace on the prevention, screening, diagnosis, and treatment of these conditions; they also discuss the importance of using good-quality sunscreen products to manage these disorders.

On May 25, 2022, Bella Aurora celebrated the International Skin Pigmentation Day. With over 130 years of experience in the research of skin pigmentation, Bella Aurora launched an international awareness campaign to celebrate the day with the support of renowned dermatologists, pharmacists, and key opinion leaders across the Spain and Italy. In June 2021, Dermalogica Clear launched a campaign to encourage skin acceptance and educate audiences on post-inflammatory hyperpigmentation, acne, breakouts, and more.

The increased awareness of melasma and other hyperpigmentation disorders has led to a surge in demand for innovative and efficacious treatment products and procedures. Moreover, it has brought about a significant and positive change in how society understands and manages hyperpigmentation. Thus, the increasing number of awareness programs bolsters the growth of the hyperpigmentation disorder treatment market.

Europe Hyperpigmentation Disorder Treatment Market Overview

The hyperpigmentation disorder treatment market in Europe is segmented into Germany, UK, France, Italy, Spain, and Rest of Europe. The Germany held the largest Europe hyperpigmentation disorder treatment market share in 2023. Factors such as increasing awareness and emphasis on skincare and dermatological health among the population driving the market growth. Germans are increasingly proactive in seeking advanced skincare solutions to address hyperpigmentation disorders such as melasma, age spots, and post-inflammatory hyperpigmentation, driving the demand for innovative treatments in the market. Additionally, the rise in the aging population in Germany has led to numerous age-related skin concerns, including hyperpigmentation, prompting individuals to seek specialized treatments to maintain radiant skin. According to the Federal Statistical Office of Germany (Statistisches Bundesamt), the number of people aged 67 and above would increase from 4 million to at least 20 million by the mid-2030s. A culture that values skin care and anti-aging solutions, coupled with population aging and high skin disease prevalence, contributes to the demand for hyperpigmentation disorder treatments in Germany. Furthermore, rising attention and concerns about appearance continue to be a key factor in increasing the demand for various cosmetic procedures, contributing to strong market growth. Moreover, the presence of advanced medical infrastructure, skilled dermatologists, and reputable cosmetic clinics in Germany contributes to the accessibility of a wide range of hyperpigmentation treatments and procedures, attracting both domestic and international patients seeking quality skin care services.

Europe Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Hyperpigmentation Disorder Treatment Market Segmentation

The Europe hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.

Based on treatment type, the Europe hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest market share in 2022.

Based on condition, the Europe hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest market share in 2022.

Based on end user, the Europe hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022.

By country, the Europe hyperpigmentation disorder treatment market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe hyperpigmentation disorder treatment market share in 2022.

AbbVie Inc, Bayer AG, EpiPharm AG, Galderma SA, L'OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Pierre Fabre SA are some of the leading companies operating in the Europe hyperpigmentation disorder treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Hyperpigmentation Disorder Treatment Market - Key Market Dynamics

  • 4.1 Europe Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Melasma
    • 4.2.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Treatments
  • 4.4 Market Opportunities
    • 4.4.1 Strategic Initiatives by Market Players
  • 4.5 Future Trends
    • 4.5.1 Use of Ablative Lasers
    • 4.5.2 Novel Products Based on PATH-3 Technology
  • 4.6 Impact of Drivers and Restraints:

5. Hyperpigmentation Disorder Treatment Market - Europe Analysis

  • 5.1 Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030

6. Europe Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type

  • 6.1 Cosmeceutical
    • 6.1.1 Overview
    • 6.1.2 Cosmeceutical: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Light or Laser Therapy
    • 6.2.1 Overview
    • 6.2.2 Light or Laser Therapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Microdermabrasion
    • 6.3.1 Overview
    • 6.3.2 Microdermabrasion: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Chemical Peels
    • 6.4.1 Overview
    • 6.4.2 Chemical Peels: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Cryotherapy
    • 6.5.1 Overview
    • 6.5.2 Cryotherapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Hyperpigmentation Disorder Treatment Market Analysis - by Condition

  • 7.1 Melasma
    • 7.1.1 Overview
    • 7.1.2 Melasma: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Solar Lentigines
    • 7.2.1 Overview
    • 7.2.2 Solar Lentigines: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Post-inflammatory Hyperpigmentation
    • 7.3.1 Overview
    • 7.3.2 Post-inflammatory Hyperpigmentation: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Hyperpigmentation Disorder Treatment Market Analysis - by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Dermatology Centers
    • 8.2.1 Overview
    • 8.2.2 Dermatology Centers: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Hyperpigmentation Disorder Treatment Market - Country Analysis

  • 9.1 Europe Hyperpigmentation Disorder Treatment Market
    • 9.1.1 Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 Germany
      • 9.1.1.3 Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.1 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 9.1.1.3.2 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 9.1.1.3.3 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 9.1.1.4 UK
      • 9.1.1.5 UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.1 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 9.1.1.5.2 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 9.1.1.5.3 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 9.1.1.6 France
      • 9.1.1.7 France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.7.1 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 9.1.1.7.2 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 9.1.1.7.3 France: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 9.1.1.8 Italy
      • 9.1.1.9 Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.9.1 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 9.1.1.9.2 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 9.1.1.9.3 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 9.1.1.10 Spain
      • 9.1.1.11 Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.11.1 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 9.1.1.11.2 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 9.1.1.11.3 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
      • 9.1.1.12 Rest of Europe
      • 9.1.1.13 Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.13.1 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
        • 9.1.1.13.2 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
        • 9.1.1.13.3 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by End User

10. Hyperpigmentation Disorder Treatment Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 AbbVie Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 EpiPharm AG
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Galderma SA
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Obagi Cosmeceuticals LLC
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Bayer AG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Lutronic Co Ltd
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 L'OREAL S.A.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Pierre Fabre SA
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms